Actonel - Risedronate sodium

Actonel (Risedronate sodium). Procter Gamble Pharmaceuticals UK Limited UK Summary of product characteristics, October 2006. 

Actonel contains risedronate sodium, a bisphosphonate. Osteonecrosis of the jaw has been reported in patients receiving oral bisphosphonates. Adequate oral hygiene should be maintained during and after treatment with bisphosphonates, including Actonel. Preventive dental treatment should be considered before starting bisphosphonates. Patient should be advised to maintain adequate oral hygiene during treatment. 

---